Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Oncology (Toronto, Ont.)|April 25, 2025
Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre PerspectiveTana Saiyin, Grace Christou, Mitchell Sabloff, et al.
Transfusion|February 11, 2012
Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantationNatasha Kekre, Grace Christou, Ranjeeta Mallick, et al.
Transfusion|July 29, 2016
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trialsGrace Christou, Ahbinav Iyengar, Risa Shorr, et al.
Transfusion|August 16, 2014
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantationGrace Christou, Natasha Kekre, William Petrcich, et al.
JCO Oncology Practice|February 10, 2023
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic SyndromesLee Mozessohn, Qing Li, Ning Liu, et al.
Annals of Hematology|February 22, 2022
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromesEugene Brailovski, Qing Li, Ning Liu, et al.
Leukemia & Lymphoma|January 6, 2023
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registryRena Buckstein, Lisa Chodirker, Karen W L Yee, et al.
British Journal of Haematology|June 1, 2021
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN studyIrina Amitai, Michelle Geddes, Nancy Zhu, et al.
Leukemia & Lymphoma|September 12, 2022
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registryRena Buckstein, Lisa Chodirker, Lee Mozessohn, et al.
Haematologica|August 18, 2022
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromesJennifer Teichman, Michelle Geddes, Nancy Zhu, et al.
Pageof 2